Related Experiment Video
Updated: Jun 21, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Tuberculosis into the 2010s: is the glass half full?
Anna P Ralph1, Nicholas M Anstey, Paul M Kelly
1International Health Division, Menzies School of Health Research, PO Box 41096, Casuarina NT 0811, Australia. annaralph@bigpond.com
Significant advancements in tuberculosis diagnostics, drugs, and treatment strategies have emerged, alongside new challenges like extensively drug-resistant TB. Updates to care standards and optimized programs offer hope for improved global tuberculosis control.
Area of Science:
- Global Health
- Infectious Diseases
- Public Health Policy
Background:
- Tuberculosis (TB) remains a global emergency, complicated by extensively drug-resistant (XDR-TB) strains and co-infection with human immunodeficiency virus (HIV).
- Over 16 years, progress has been made despite emerging challenges, necessitating an update to existing care standards.
Purpose of the Study:
- To review advancements in TB diagnostics, therapeutics, and control strategies since TB was declared a global emergency.
- To propose updates to the International Standards of Tuberculosis Care to incorporate recent developments.
- To advocate for optimized control programs and increased political will.
Main Methods:
- Literature review and synthesis of advancements in TB diagnostics and drug development.
- Analysis of treatment outcomes for multidrug-resistant TB (MDR-TB) and XDR-TB.
- Evaluation of strategies for managing co-infections and nosocomial transmission.
Main Results:
- Improvements in TB diagnostics and a pipeline of new candidate drugs.
- Enhanced treatment outcomes for MDR-TB and XDR-TB.
- Increased recognition of nosocomial transmission and improved HIV-TB co-infection management.
Conclusions:
- Recent scientific and programmatic achievements provide a basis for improved TB control.
- Updating the International Standards of Tuberculosis Care is crucial.
- Optimized directly observed treatment, short course (DOTS) programs, political will, and widespread deployment are essential for enhanced global TB control.
Related Concept Videos
Tuberculosis
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

